References
- Van der Veen MJ, Dekker JJ, Dinant HJ, van Soesbergen RM, Bulsma JWJ. Fatal pulmonary fibrosis complicating low dose meth-otrexate therapy for rheumatoid arthritis. J Ftheumatol 1995;22: 1766–8.
- Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activ-ity: sialylated carbohydrate antigen KL-6. Chest 1989;96:68–73.
- Searles G, McKendry R Jr. Methotrexate pneumonitis in rheuma-toid arthritis: potential risk factors; four case reports and a review of the literature. J Ftheumatol 1987;14:1164–71.
- Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 1997;156:109–15.